UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 47

Sortiert nach

Encryption algorithm "QAMAL NPNS" based on a nonpositional polynomial notation

Vestnik KazNU. Serii͡a︡ matematika, mekhanika, informatika, 2020-04, Vol.105 (1)

2020

Volltextzugriff (PDF)

Алгоритм шифрования "QAMAL NPNS"с использованием непозиционной полиномиальной системы счисления

Vestnik KazNU. Serii͡a︡ matematika, mekhanika, informatika, 2020-04, Vol.105 (1), p.198-207

2020

Volltextzugriff (PDF)

DEVELOPMENT AND ANALYSIS OF THE ENCRYPTION ALGORITHM IN NONPOSITIONAL POLYNOMIAL NOTATIONS

Eurasian Journal of Mathematical and Computer Applications, 2018, Vol.6 (2), p.19-33

2018

Volltextzugriff (PDF)

Combined MTOR and autophagy inhibition: Phase I trial of hydroxychloroquine and temsirolimus in patients with advanced solid tumors and melanoma

Autophagy, 2014-08, Vol.10 (8), p.1391-1402

2014

Volltextzugriff (PDF)

Health information on the Internet: accessibility, quality, and readability in English and Spanish

JAMA : the journal of the American Medical Association, 2001-05, Vol.285 (20), p.2612

2001

Volltextzugriff (PDF)

Factors predicting severe radiation pneumonitis in patients receiving definitive chemoradiation for lung cancer

International journal of radiation oncology, biology, physics, 2000-08, Vol.48 (1), p.89-94

2000

Volltextzugriff (PDF)

Factors Affecting the Risk of Brain Metastases After Definitive Chemoradiation for Locally Advanced Non–Small-Cell Lung Carcinoma

Journal of clinical oncology, 2001-03, Vol.19 (5), p.1344-1349

2001

Volltextzugriff (PDF)

Differential Cryptanalysis of New Qamal Encryption Algorithm

International Journal of Electronics and Telecommunications, 2020-01, Vol.66 (4), p.647-653

2020

Volltextzugriff (PDF)

Dynamics and rigidity of a manipulator with three DOFs

MATEC Web of Conferences, 2018, Vol.226, p.1020

2018

Volltextzugriff (PDF)

Mechanical analysis of vibratory conveyor mechanism

MATEC Web of Conferences, 2018, Vol.226, p.1019

2018

Volltextzugriff (PDF)

Stereotactic Body Radiation Therapy for Oligometastatic Pulmonary Lesions

International journal of radiation oncology, biology, physics, 2014-11, Vol.90 (5), p.S41-S42

2014

Volltextzugriff (PDF)

Stereotactic Body Radiation Therapy for Oligometastatic Pulmonary Lesions

International journal of radiation oncology, biology, physics, 2014-09, Vol.90 (1), p.S626-S626

2014

Volltextzugriff (PDF)

Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non–small cell lung carcinoma: long-term results and associations with pathologic response

The Journal of thoracic and cardiovascular surgery, 2004, Vol.127 (1), p.108-113

2004

Volltextzugriff (PDF)

Differential Cryptanalysis of New Qamal Encryption Algorithm

International Journal of Electronics and Telecommunications, 2020-07, p.647-653

2020

Volltextzugriff (PDF)

A Single Institution Experience With Induction Chemotherapy (ICT) Followed by Chemoradiation (CRT) Versus CRT for Definitive Treatment of Locally Advanced Squamous Cell Carcinoma of the Head and Neck (LA-SCCHN)

International journal of radiation oncology, biology, physics, 2012-11, Vol.84 (3), p.S526-S527

2012

Volltextzugriff (PDF)

Stereotactic Body Radiation Therapy for Oligometastatic Pulmonary Lesions: Metastatic Non-Small Cell Lung Cancer

International journal of radiation oncology, biology, physics, 2014-11, Vol.90 (5), p.S41-S42

2014

Volltextzugriff (PDF)

A population-based study of lung carcinoma in pennsylvania : Comparison of veterans administration and civilian populations

Cancer, 2005-08, Vol.104 (4), p.833-840

2005

Volltextzugriff (PDF)

Spinner's Hematuria

The New England journal of medicine, 2002-05, Vol.346 (21), p.1676-1676

Algazy, Kenneth M

2002

Volltextzugriff (PDF)

Warfarin-Induced Skin Necrosis in a Patient with a Mutation of the Prothrombin Gene

The New England journal of medicine, 1999-03, Vol.340 (9), p.735-735

1999

Volltextzugriff (PDF)

Phase I Trial of the Cryptophycin Analogue LY355703 Administered as an Intravenous Infusion on a Day 1 and 8 Schedule Every 21 Days

Clinical cancer research, 2002-08, Vol.8 (8), p.2524-2529

2002

Volltextzugriff (PDF)

Phase I Clinical and Pharmacogenetic Trial of Irinotecan and Raltitrexed Administered Every 21 Days to Patients With Cancer

Journal of clinical oncology, 2001-10, Vol.19 (20), p.4081-4087

2001

Volltextzugriff (PDF)

Abstract 4500: Combined mTOR inhibition and autophagy inhibition: Phase I trial of temsirolimus and hydroxchloroquine in patients with advanced solid tumors

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.4500-4500

2011

Volltextzugriff (PDF)

A phase I, dose escalation trial of ZD0473, a novel platinum analogue, in combination with gemcitabine

Cancer chemotherapy and pharmacology, 2004-05, Vol.53 (5), p.404-408

2004

Volltextzugriff (PDF)

A randomized phase II study of cetuximab (C) every 2 weeks at either 500 or 750 mg/m 2 for patients (Pts) with recurrent or metastatic (R/M) head and neck squamous cell cancer (HNSCC)

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.5563-5563

2011

Volltextzugriff (PDF)

Phase I and Pharmacokinetic Trial of the Proapoptotic Sulindac Analog CP-461 in Patients with Advanced Cancer

Clinical cancer research, 2002-10, Vol.8 (10), p.3100-3104

2002

Volltextzugriff (PDF)

1 – 25 von 47

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(45)
Mit Volltextzugriff
(43)

Publikationsform

Artikel
(45)
Tagungsberichte
(2)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(25)
Humans
(24)
Life Sciences & Biomedicine
(23)
Male
(19)
Female
(18)
Middle Aged
(17)
Aged
(16)
Biological And Medical Sciences
(16)
Medical Sciences
(16)
Oncology
(15)
Adult
(14)
Pharmacology. Drug Treatments
(11)
Antineoplastic Agents
(10)
Neoplasms - Drug Therapy
(9)
Dose-Response Relationship, Drug
(8)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(7)
Aged, 80 And Over
(6)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(6)
Combined Modality Therapy
(6)
Treatment Outcome
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Encryption algorithm "QAMAL NPNS" based on a nonpositional polynomial notation

Алгоритм шифрования "QAMAL NPNS"с использованием непозиционной полиномиальной системы счисления

DEVELOPMENT AND ANALYSIS OF THE ENCRYPTION ALGORITHM IN NONPOSITIONAL POLYNOMIAL NOTATIONS

Combined MTOR and autophagy inhibition: Phase I trial of hydroxychloroquine and temsirolimus in patients with advanced solid tumors and melanoma

Health information on the Internet: accessibility, quality, and readability in English and Spanish

Factors predicting severe radiation pneumonitis in patients receiving definitive chemoradiation for lung cancer

Factors Affecting the Risk of Brain Metastases After Definitive Chemoradiation for Locally Advanced Non–Small-Cell Lung Carcinoma

Differential Cryptanalysis of New Qamal Encryption Algorithm

Dynamics and rigidity of a manipulator with three DOFs

Mechanical analysis of vibratory conveyor mechanism

Stereotactic Body Radiation Therapy for Oligometastatic Pulmonary Lesions

Stereotactic Body Radiation Therapy for Oligometastatic Pulmonary Lesions

Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non–small cell lung carcinoma: long-term results and associations with pathologic response

Differential Cryptanalysis of New Qamal Encryption Algorithm

A Single Institution Experience With Induction Chemotherapy (ICT) Followed by Chemoradiation (CRT) Versus CRT for Definitive Treatment of Locally Advanced Squamous Cell Carcinoma of the Head and Neck (LA-SCCHN)

Stereotactic Body Radiation Therapy for Oligometastatic Pulmonary Lesions: Metastatic Non-Small Cell Lung Cancer

A population-based study of lung carcinoma in pennsylvania : Comparison of veterans administration and civilian populations

Spinner's Hematuria

Warfarin-Induced Skin Necrosis in a Patient with a Mutation of the Prothrombin Gene

Phase I Trial of the Cryptophycin Analogue LY355703 Administered as an Intravenous Infusion on a Day 1 and 8 Schedule Every 21 Days

Phase I Clinical and Pharmacogenetic Trial of Irinotecan and Raltitrexed Administered Every 21 Days to Patients With Cancer

Abstract 4500: Combined mTOR inhibition and autophagy inhibition: Phase I trial of temsirolimus and hydroxchloroquine in patients with advanced solid tumors

A phase I, dose escalation trial of ZD0473, a novel platinum analogue, in combination with gemcitabine

A randomized phase II study of cetuximab (C) every 2 weeks at either 500 or 750 mg/m 2 for patients (Pts) with recurrent or metastatic (R/M) head and neck squamous cell cancer (HNSCC)

Phase I and Pharmacokinetic Trial of the Proapoptotic Sulindac Analog CP-461 in Patients with Advanced Cancer

Suchergebnisse filtern